Suppr超能文献

两种新的互补性连续视程多焦点人工晶状体联合植入术后 3 个月和 12 个月的视觉性能和主观体验。

Visual performance and subjective experience 3 months and 12 months after combined implantation of 2 new complementary continuous phase multifocal intraocular lenses.

机构信息

From the Cathedral Eye Clinic, Belfast, Northern Ireland, United Kingdom (McNeely, Stewart, Moore); School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Northern Ireland, United Kingdom (Stewart); College of Health and Life Sciences, Aston University, Birmingham, United Kingdom (Moore); Tianjin Medical University, Tianjin, China (Moore).

出版信息

J Cataract Refract Surg. 2023 Sep 1;49(9):921-928. doi: 10.1097/j.jcrs.0000000000001236.

Abstract

PURPOSE

To assess the 3-month and 12-month postoperative visual performance and subjective quality of vision (QoV) after combined implantation of complementary continuous phase multifocal intraocular lenses (IOLs).

SETTING

Private practice, United Kingdom.

DESIGN

Case series.

METHODS

The study enrolled 44 patients undergoing phacoemulsification with implantation of an Artis Symbiose Mid in the dominant eye and an Artis Symbiose Plus in the nondominant eye. Refraction, uncorrected distance visual acuity (UDVA), corrected distance visual acuity, uncorrected intermediate visual acuity (UIVA), uncorrected near visual acuity (UNVA), electronic reading desk, and a QoV questionnaire were evaluated at 3 months and 12 months postoperatively.

RESULTS

The mean binocular UDVA was -0.06 ± 0.08 logMAR and -0.07 ± 0.06 logMAR at 3 months and 12 months ( P = .097), respectively. The mean binocular UIVA was 0.03 ± 0.13 logMAR and 0.03 ± 0.10 logMAR ( P = 1.0), respectively. The mean binocular UNVA was 0.07 ± 0.10 logMAR and 0.07 ± 0.08 logMAR ( P = .875), respectively. There was a significant improvement in QoV for both day and night between 3 and 12 months, with a significant reduction in halos at 12 months. Spectacle independence was reported in 93.2% of cases at 12 months.

CONCLUSIONS

The Artis Symbiose Mid and Plus IOL combined implantation provided an excellent range of uncorrected vision at 3 and 12 months. There was a significant improvement in QoV and less halos at 12 months. This IOL combination provided very high rates of complete spectacle independence.

摘要

目的

评估联合植入互补连续相位多焦点人工晶状体(IOL)后 3 个月和 12 个月的术后视觉表现和主观视觉质量(QoV)。

设置

英国私人诊所。

设计

病例系列。

方法

该研究纳入了 44 例接受超声乳化白内障吸除术的患者,在优势眼植入 Artis Symbiose Mid,在非优势眼植入 Artis Symbiose Plus。术后 3 个月和 12 个月分别评估屈光度、未矫正远视力(UDVA)、矫正远视力、未矫正中间视力(UIVA)、未矫正近视力(UNVA)、电子阅读台和 QoV 问卷。

结果

双眼平均 UDVA 分别为 -0.06 ± 0.08 logMAR 和 -0.07 ± 0.06 logMAR(P=0.097)。双眼平均 UIVA 分别为 0.03 ± 0.13 logMAR 和 0.03 ± 0.10 logMAR(P=1.0)。双眼平均 UNVA 分别为 0.07 ± 0.10 logMAR 和 0.07 ± 0.08 logMAR(P=0.875)。3 个月至 12 个月期间,QoV 白天和夜间均有显著改善,12 个月时光晕显著减少。12 个月时,93.2%的病例报告无需戴眼镜。

结论

Artis Symbiose Mid 和 Plus IOL 联合植入可在 3 个月和 12 个月时提供出色的未矫正视力。12 个月时 QoV 显著改善,光晕减少。这种 IOL 组合提供了非常高的完全不戴眼镜的比例。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验